Search clinical trials for: Injection drug users

Total 262187 results

Institute of Health Information and Statistics...
Institute for Clinical and Experimental Medicine; Brno University Hospital; University... and other collaborators

Recruiting

Early Detection of HCV in Injection Drug Users (EDVIP)

Hepatitis C Virus Infection

Czechia
Ain Shams University
Misr International University; University of Nizwa

Recruiting

Chitosan-Hyaluronate Gel Mixture Vs Hyaluronic for Internal Derangement (TMJ)

TMJ Disc Disorder

Egypt
Gilead Sciences
National Institute on Drug Abuse (NIDA); National Institute of Allergy and... and other collaborators

Recruiting

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103) (PURPOSE 4)

Pre-Exposure Prophylaxis of HIV Infection

United States
McGill University

Completed

A Novel mHealth Application Guided by an Optimization Algorithm for T1D Sensor-Augmented Insulin Injection Users

Diabetes Mellitus | Diabetes Mellitus, Type 1

Canada
Indivior Inc.

Active, not recruiting

Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users

Moderate to Severe Opioid-use Disorder

United States, Canada
Haisco-USA Pharmaceuticals, Inc.

Completed

Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users

General Anesthesia

United States
Tedec-Meiji Farma, S.A.

Completed

Efficacy and Safety of Repeated Intraarticular Injections of Hyaluronic Acid in Patients With OA of the Knee

Osteoarthritis of the Knee
Center For Hepatitis C, Atlanta, GA

Active, not recruiting

Treatment of HCV-Infected Recent Injection Drug Users in U.S. Liver Clinics

Chronic Hepatitis C | People Who Inject Drugs

United States
National Opinion Research Center
Merck Sharp & Dohme LLC; Emory University; Grady Health System

Terminated

Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial Hospital (EZ-C)

Hepatitis C

United States
University of Pennsylvania

Withdrawn

Oritavancin for Staphylococcus Aureus Infections in Opioid Users

Staphylococcus Aureus Bacteremia | Staphylococcus Aureus Endocarditis

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)

HIV Infection | Hepatitis C

United States
National Institute of Allergy and Infectious Diseases...
National Institute on Drug Abuse (NIDA)

Terminated

Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users

HIV Infections | Opioid-Related Disorders

China, Thailand
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

HIV Infections | Lymphoma, Non-Hodgkin

United States
Prisma Health-Upstate
Albert Einstein College of Medicine; Clemson University

Completed

Intensive Models of HCV Care for Injection Drug Users

Hepatitis C | Medication Adherence

United States
University Hospital, Montpellier

Completed

: Bacterial Infections in Injecting Drug Users

Bacterial Infection

France
Butler Hospital

Completed

Preventing Bacterial and Viral Infections Among Injection Drug Users

HIV | Bacterial Infection

United States
Steffanie Strathdee
National Institute on Drug Abuse (NIDA); San Diego State University; University... and other collaborators

Completed

Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in Mexico (FSW-IDU)

HIV Infections | HIV

Mexico
Shanghai Mental Health Center

Completed

Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

Hepatitis C

China
Kirby Institute
Merck Sharp & Dohme LLC

Completed

A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3 (ACTIVATE)

Hepatitis C, Chronic

Australia, Canada, United Kingdom, Belgium, Germany, Norway, Switzerland
University of Colorado, Denver
National Institute on Drug Abuse (NIDA)

Completed

Peer Leaders as HIV Risk Reduction Change Agents Among Injection Drug Users (IDUs) in Ukraine

HIV Infection | HIV Risk Behaviors

Ukraine
Johns Hopkins University
American Thoracic Society

Completed

A Study of Novel Smoking Cessation Interventions in Current and Former Injection Drug Users

Tobacco Dependence

United States
National Cancer Institute (NCI)

Completed

HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers

HIV Infections | Lung Cancer | Drug Addiction | AIDS | Tobacco Addiction

United States
CytoDyn, Inc.

Withdrawn

A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence

HIV

United States
Centre hospitalier de l'Université de Montréal...
Fonds de la Recherche en Santé du Québec

Terminated

Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care

Active or Ex-injection Drug Users | Indication of Hepatitis C Screening

Canada
National Institute on Drug Abuse (NIDA)
University of Washington

Completed

Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users

Substance-Related Disorders | Hepatitis

United States
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Evaluation of a Multi-disciplinary Approach for the Treatment of Hepatitis C in IDUs (HI-LO Study)

Hepatitis C Virus Infection

Canada
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta, Indonesia (JAKPRO)

HIV Risk Behaviors | Heroin Injection | Retention in Methadone Treatment

Indonesia
The City College of New York
National Institute on Drug Abuse (NIDA); Johns Hopkins University

Completed

Neurobehavioral Model of HIV in Injection Drug Users

HIV Infections | Drug Abuse

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Indigenous Outreach Among Injection Drug Users to Treat and Control TB

Lung Diseases | Tuberculosis
Butler Hospital
Boston Medical Center

Completed

Linking Hospitalized Injection Drug Users to Buprenorphine

Opiate Dependence

United States
Butler Hospital
National Institute on Drug Abuse (NIDA)

Completed

A Trial to Reduce Hepatitis C Among Injection Drug Users - 1

HCV Negative Status | HCV Risk Behavior

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin

HIV | Heroin Dependence | Cocaine-Related Disorders

United States
Rockefeller University

Completed

Correlates and Consequences of Increased Immune Activation in Injection Drug Users

Intravenous Drug Usage

United States
University of Connecticut
National Institute on Drug Abuse (NIDA); APT Foundation, Inc.

Completed

Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users

HIV | Opioid Dependence

United States
University of California, San Francisco
National Institute on Drug Abuse (NIDA)

Completed

A Randomized Trial of Vaccine Adherence in Young Injection Drug Users (UFO VAX)

Substance Abuse, Intravenous | Risk Behavior | Hepatitis B | Hepatitis A | Hepatitis C | Medication Adherence

United States
Butler Hospital
National Institute of Mental Health (NIMH)

Completed

Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users

Substance-Related Disorders | Depression | HIV Infections

United States
Butler Hospital
National Institute of Mental Health (NIMH)

Completed

Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users

Substance-Related Disorders | Depression | HIV Infections

United States
State University of New York - Upstate Medical...

Completed

Improving Hepatitis C Treatment in Injection Drug Users

Liver Diseases | Alcoholism | Hepatitis C | Drug Abuse

United States
Centers for Disease Control and Prevention
Health Services Resource Adminstration - HIV/AIDS Bureau

Completed

Behavioral Intervention Trial for HIV-infected Injection Drug Users

HIV

United States
Centers for Disease Control and Prevention

Completed

Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users

HIV Infections | Hepatitis C

United States
National Cancer Institute (NCI)

Completed

Validation of Self-Reported Needle Sharing Among Injection Drug Users

Viral Infection

United States
Yale University
National Institute on Drug Abuse (NIDA); Case Western Reserve University; DePaul... and other collaborators

Completed

Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules (HVS)

Hepatitis B

United States
National Institute of Allergy and Infectious Diseases...
National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute... and other collaborators

Completed

A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts

HIV Infections

United States, Thailand
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV

Hepatitis C Virus Infection

Canada
Organization to Achieve Solutions in Substance...
Centers for Disease Control and Prevention

Completed

A Video-Based HCV Curriculum for Active Injection Drug Users

Hepatitis C | Opiate Dependence

United States
Pfizer

Completed

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

Contraception | Bone Density

United States
Chiron Corporation

Unknown

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

HIV Infections

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Unknown

Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users

Tuberculosis
S.LAB (SOLOWAYS)
Center of New Medical Technologies

Not yet recruiting

Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer

Breast Cancer

Russian Federation
First Affiliated Hospital of Zhejiang University
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Recruiting

Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AML

Myeloid Malignancy | Relapsed/Refractory Acute Myeloid Leukaemia

China

Search clinical trials for: Injection drug users

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations